1. Home
  2. AVTX vs BEDU Comparison

AVTX vs BEDU Comparison

Compare AVTX & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • BEDU
  • Stock Information
  • Founded
  • AVTX 2011
  • BEDU 1994
  • Country
  • AVTX United States
  • BEDU United Kingdom
  • Employees
  • AVTX N/A
  • BEDU N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • BEDU Other Consumer Services
  • Sector
  • AVTX Health Care
  • BEDU Real Estate
  • Exchange
  • AVTX Nasdaq
  • BEDU Nasdaq
  • Market Cap
  • AVTX 57.4M
  • BEDU 47.7M
  • IPO Year
  • AVTX 2015
  • BEDU 2017
  • Fundamental
  • Price
  • AVTX $4.41
  • BEDU $1.81
  • Analyst Decision
  • AVTX Strong Buy
  • BEDU
  • Analyst Count
  • AVTX 6
  • BEDU 0
  • Target Price
  • AVTX $34.20
  • BEDU N/A
  • AVG Volume (30 Days)
  • AVTX 62.6K
  • BEDU 9.6K
  • Earning Date
  • AVTX 05-12-2025
  • BEDU 04-28-2025
  • Dividend Yield
  • AVTX N/A
  • BEDU N/A
  • EPS Growth
  • AVTX N/A
  • BEDU N/A
  • EPS
  • AVTX N/A
  • BEDU N/A
  • Revenue
  • AVTX $441,000.00
  • BEDU $224,321,752.00
  • Revenue This Year
  • AVTX N/A
  • BEDU N/A
  • Revenue Next Year
  • AVTX N/A
  • BEDU N/A
  • P/E Ratio
  • AVTX $0.59
  • BEDU N/A
  • Revenue Growth
  • AVTX N/A
  • BEDU N/A
  • 52 Week Low
  • AVTX $3.39
  • BEDU $1.35
  • 52 Week High
  • AVTX $16.00
  • BEDU $2.42
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 45.63
  • BEDU 58.87
  • Support Level
  • AVTX $3.43
  • BEDU $1.76
  • Resistance Level
  • AVTX $4.03
  • BEDU $1.81
  • Average True Range (ATR)
  • AVTX 0.34
  • BEDU 0.07
  • MACD
  • AVTX 0.09
  • BEDU 0.02
  • Stochastic Oscillator
  • AVTX 70.47
  • BEDU 75.81

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

Share on Social Networks: